Genetic instability of tumor cells often leads to the occurrence of a large number of
mutations, and expression of non-synonymous mutations can produce tumor-specific …

Vaccination was first pioneered in the 18th century by Edward Jenner and eventually led to
the development of the smallpox vaccine and subsequently the eradication of smallpox. The …

Dendritic cell (DC) vaccine was among the first FDA-approved cancer immunotherapies, but
has been limited by the modest cytotoxic T lymphocyte (CTL) response and therapeutic …

Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer
immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV …

Metastasis is directly or indirectly responsible for the majority of cancer deaths. Anti-
metastasis treatment is thus the key to cure cancer. Recent development in nanomedicine …

Ongoing COVID-19 outbreak has raised a drastic challenge to global public health security.
Most of the patients with COVID-19 suffer from mild flu-like illnesses such as cold and fever; …

Tumor tissues/cells are the best sources of antigens to prepare cancer vaccines. However,
due to the difficulty of solubilization and delivery of water‐insoluble antigens in tumor …

The textbook of “Phytochemistry and bioactive compounds”, Volume 2 of the series—
Therapeutic use of Medicinal Plants and their Extracts, has been written to meet the needs of …

Persistent infection with human papillomavirus (HPV) initiates~ 5% of all human cancers,
and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection …

Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with
potential to provide greater clinical benefit to patients with advanced-stage cancer. In …